-
The San Francisco-based AI juggernaut says it is re-evaluating its policies around "NSFW" content.
-
A drug company will voluntarily stop selling a medicine that was bringing in hundreds of millions of dollars, keeping a promise the business made years earlier to people with the fatal condition ALS.
-
Closing arguments in the United States v. Google monopoly trial have wrapped up. How the judge decides this case could set a precedent for several other antitrust suits against Big Tech companies.
-
The children of sex workers rarely see doctors and are often living in brothels. Their deaths frequently go unnoticed and undocumented.
-
When marijuana becomes a Schedule III instead of a Schedule I substance under federal rules, researchers will face fewer barriers to studying it. But there will still be some roadblocks for science.
-
Siblings — especially twins — sometimes share the strangest traits, like throwing a ball with their head or picking up keys and crayons with their toes. Researchers want to know what's up with that.
-
For decades, nonprofits, health insurers and hospitals have been trying to solve the problem of the people who need the emergency room again and again. Here are some of the lessons they've learned.
-
President Biden addresses pro-Palestinian protests. Monopoly trial between DOJ and Google is wrapping up. Protesters in the Caucasus nation of Georgia say Russia-style draft law will hurt free speech.
-
A major antitrust trial over Google's search engine is coming to a close. It boils down to this point: Is Google an illegal monopoly that's pushed out rivals — or is it simply the best search engine?
-
Michael Sanchez was testing out his new camera when he happened upon a feathered subject. The blue rock-thrush he photographed on the coast of northern Oregon last week has excited the birding world.
-
The bill which was previously passed in the House in 2019 and 2022 but blocked in the Senate, aims to end race-based hair discrimination in schools and workplaces.
-
Federal health officials say the U.S. has the building blocks to make a vaccine to protect humans from bird flu, if needed. But experts warn we're nowhere near prepared for another pandemic.